Hypoxia-induced Extracellular Vesicles Mediate Protection of Remote Ischemic Preconditioning for Renal Ischemia-Reperfusion Injury

Guangyuan Zhang,Yu Yang,Yeqing Huang,Lei Zhang,Zhixin Ling,Yingjian Zhu,Feng Wang,Xiangyu Zou,Ming Chen
DOI: https://doi.org/10.1016/j.biopha.2017.03.096
IF: 7.419
2017-01-01
Biomedicine & Pharmacotherapy
Abstract:Remote ischemic preconditioning (rIPC) is a reliable strategy for prevention of injury to various organs. However the mechanism by which it does so is still unclear. In the present study, serum and EVs isolated from ischemic preconditioned right renal venous perfusates were injected into rats with ischemia-reperfusion-injured kidneys immediately after reperfusion. The animals were killed 24h later. Tubular scores and renal function were tested to evaluate the therapeutic effects. To further explore the underlying mechanism, HK-2 cells derived EVs under hypoxia were also administrated to rats with left kidney IRI. Results showed that transient ischemia of the right kidney induced renal tubular epithelial cells to release functional extracellular vesicles (EVs), which were found to alleviate left kidney ischemic reperfusion injury (IRI) by circulation and the EV-depleted serum lost this property. Further, human kidney cells (HK2) were cultured under hypoxic conditions to generate EVs in vitro. These EVs also showed obvious therapeutic effects for renal IRI. Our results suggested that remote ischemic preconditioning plays a therapeutic role in renal IRI through EVs induced by hypoxia.
What problem does this paper attempt to address?